Aptevo Therapeutics Inc.
APVO· Nasdaq
APVOAptevo Therapeutics Inc.
Filed Aug 25, 2016 · 10-Q · 56 days after period end · 0001564590-16-024734
| Metric | Q2 2016 | Q2 2015 |
|---|---|---|
| Revenue | $10.19M | $7.09M |
| Net Income | -$12.84M | -$17.72M |
| EPS Diluted | -$0.63 | -$0.88 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aptevo Therapeutics Inc. · CIK 1671584 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Aug 25, 2016 · 56 d after period end
